Studies of the initial anticoagulant response in tissue-thromboplastin induced intravascular coagulation

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 6, 1996, Pages 595-601

  Tvedskov, T F ^a   Vad, H ^a   Bendix Hansen, K ^a   Albrechtsen, O K ^a   Gram, J ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

antithrombin; fibrinolysis; intravascular coagulation; protein C; tissue thromboplastin

Indexed keywords

ANTIPLASMIN; FIBRINOGEN; PLASMINOGEN; PROTEIN C; THROMBOPLASTIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; THROMBOSIS;

EID: 0029801878     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199609000-00004     Document Type: Article

References (33)

1. Rivers RPA, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-315.
2. Østerud B, Flægstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49: 5-7.
3. Astrup T, Jespersen J. Thrombosis, disseminated intravascular coagulation, and the dynamic haemostatic balance. Aspects of prophylaxis and treatment. Int Angiol 1984; 3: 331-342.
4. Wardle EN. Coagulation problems in the intensive care patient. Care Crit II 1993; 9: 246-249.
5. Bick RL. Disseminated intravascular coagulation: objective criteria for clinical and laboratory diagnosis and assessment of therapeutic response. Clin Appl Thrombosis/Hemostasis 1995; 1: 3-23.
6. Taylor FB, Chang A, Esmon CT, et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918-925.
7. Taylor F, Chang A, Ferrell G, et al. C4b-binding protein exacerbates the host response to Escherichia coli. Blood 1991; 78: 357-363.
8. Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood 1991; 78: 1496-1502.
9. a/phospholipid-induced intravascular coagulation in rabbits. Effects of immunodepletion of tissue factor pathway inhibitor. Arterioscl Thromb 1993; 13: 1551-1557.
10. Dickneite G, Pâques E-P. Reduction of mortality with antithrombin III in septic rats: a study of Klebsiella pneumonia induced sepsis. Thromb Haemost 1993; 69: 98-102.
11. Beller FK, Mitchell PS, Gorstein F. Fibrin deposition in the rabbit kidney produced by protease inhibitors. Thromb Diath Haemorrh 1967; 17: 429-438.
12. Diffang C, Saldeen T. Effect of trasylol on fibrin deposition and elimination in the lungs of rats with intravascular coagulation induced by thrombin or thromboplastin. Thromb Res 1974; 5: 263-276.
13. Jespersen J, Sidelmann J. A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen. Acta Haematol 1982; 67: 2-7.
14. Gram J, Jespersen J. Increased concentration of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III. Clin Chem 1989; 35: 52-55.
15. Gram J, Jespersen J. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples. Thromb Haemost 1985; 53: 255-259.
16. 2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Thromb Haemost 1983; 50: 581-585.
17. Jespersen J, Astrup T. A study of the fibrin plate assay of fibrinolytic agents: optimal conditions, reproducibility and precision. Haemostasis 1983; 13: 301-315.
18. Hansen KB, Aabo K, Myhre-Jensen O. Response of pulmonary (circulating) megakaryocytes to experimentally induced consumption coagulopathy in rabbits. Acta Path Microbiol Scand Sect A 1979; 87: 165-172.
19. Beneke G. Demonstration of plasma proteins in microscopic sections with emphasis on the identification of fibrin. In: Bang NU, Beller FK, Deutz E, Mammen EF, eds. Thrombosis and Bleeding Disorders. Stuttgart: Georg Thieme Verlag, 1971: 524-534.
20. Albrechtsen OK, Brakman P, Astrup T. The defibrination syndrome in rabbits following infusion of tissue thromboplastin in the jugular vein. Thromb Diath Haemorrh 1970; 24: 113-128.
21. Triantaphyllopoulos DC. Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemost 1984; 51: 232-235.
22. Madden RM, Ward M, Marlan RA. Protein C activity levels in endotoxin-induced disseminated intravascular coagulation in a dog model. Thromb Res 1989; 55: 297-307.
23. Zawilska K, Zozulinska M, Turowiecka Z, Baũhũt M, Drobnik L, Vinazzer H. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbit. Thromb Res 1993; 69: 315-320.
24. Brandt P, Jespersen J, Gregersen G. Postpartum haemolytic-ureamic syndrome successfully treated with antithrombin-III. Br Med J 1980; 280: 449.
25. Wilson RF, Mammen EF, Robson MC, Heggers JP, Soullier G, DePoli PA. Antithrombin, prekallikrein, and fibronectin levels in surgical patients. Arch Surg 1985; 121: 635-640.
26. Brandtzaeg P, Sandset PM, Joø GB, Ørstebø R, Abildgaard U, Kierulf P. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res 1989; 55: 459-470.
27. Hesselvik JF, Malm J, Dahlbäck B, Blombäck M. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991; 65: 126-129.
28. Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 1992; 101: 816-823.
29. Sandset PM, Warn-Cramer BJ, Rao LVM, Maki SL, Rapaport SI. Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to intravascular coagulation induced with tissue factor: evidence supporting a physiologic role of EPI as a natural anticoagulant. Proc Natl Acad Sci USA 1991; 88: 708-712.
30. Day KC, Hoffmann LC, Palmier MO, et al. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit. Blood 1990; 76: 1538-1545.
31. Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of antitissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-1489.
32. Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985; 66: 59-63.
33. Fijnvandraat K, Derkx B, Peters M, et al. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality. Thromb Haemost 1995; 73: 15-20.